openPR Logo
Press release

Antimicrobial Susceptibility Testing Market worth $4.2 billion by 2025 - Leading Key Players are bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US)

01-18-2021 03:08 PM CET | Health & Medicine

Press release from: MarketsandMarkets™

Antimicrobial Susceptibility Testing Market

Antimicrobial Susceptibility Testing Market

According to the new market research report "Antimicrobial Susceptibility Testing Market by Product (Manual, Automated Susceptibility Testing System), Type (Antibacterial, Antifungal), Application (Clinical Diagnostics), Method (ETEST, Disk Diffusion), End-User - Global Forecasts to 2025", published by MarketsandMarkets™, the Antimicrobial Susceptibility Testing Market is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period.

Browse in-depth TOC on "Antimicrobial Susceptibility Testing Market"
135 – Tables
40 – Figures
220 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206359984&utm_source=openpr&utm_medium=paidpr

The growth of this market is mainly driven by the growing number of hospitals across major markets, increasing awareness about diagnosis and the treatment of hospital-acquired infections coupled with the increasing adoption of rapid AST methods. Moreover, rising R&D investments by the key players operating in the market to develop genetics and genotyping-based AST solutions coupled with growing funding & grants for AST-related research are other important factors to drive the market growth in the near future.

The susceptibility testing disks subsegment of manual antimicrobial susceptibility testing products to hold major market share by 2025

Based on the product, the antimicrobial susceptibility testing market is segmented into automated laboratory instruments, manual antimicrobial susceptibility testing products, culture and growth media, and consumables. The manual susceptibility testing products segment is further divided into susceptibility testing disks, MIC strips, and susceptibility testing plates. Among the manual antimicrobial susceptibility testing products, the susceptibility testing disks segment held a major share of the market in 2019. The high quality, low cost, and ease of use of these products are increasing the adoption of susceptibility testing disks in emerging countries. Some prominent players offering susceptibility testing disks include BD (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), and HiMedia Laboratories (India).

Based on type, the antibacterial susceptibility testing systems segment is expected to account for the largest share of the AST Market in 2019

Based on type, the market has been segmented into the antibacterial susceptibility testing, antifungal susceptibility testing, antiparasitic susceptibility testing, and susceptibility testing types. Among these, the antibacterial susceptibility testing segment dominated the market in 2019. The major share of the segment is attributed to the presence of regulatory guidelines to streamline the process of antibacterial susceptibility testing, technological advancements, and the rising burden of antibacterial resistance in developing as well as developed countries.

The clinical diagnostics segment is expected to register the highest growth rate during the forecast period

Based on application, the antimicrobial susceptibility testing market has been segmented into the market is segmented into clinical diagnostics, drug discovery and development, epidemiology, and other applications. Significant market growth in the clinical diagnostics segment can be attributed to the rising burden of infectious diseases, the growing burden of antimicrobial resistance, and new product launches in the market.

Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=206359984&utm_source=openpr&utm_medium=paidpr

North America is expected to dominate the global AST market in 2019

North America, comprising the US and Canada, accounted for the largest share of the antimicrobial susceptibility testing market in 2019. Technological advancements in rapid antimicrobial susceptibility testing systems, rising incidence of infectious diseases (such as AIDS, tuberculosis, and pertussis), and government support for antimicrobial resistance-related research are the major factors driving market growth in North America. As AST through conventional methods is a lengthy process, customers in North America are moving towards rapid AST techniques, which require minimal reagents. This trend will have a positive impact on the automated instruments market.

bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), Roche Diagnostics Limited (Switzerland), Accelerate Diagnostics, Inc. (US), Merck KGaA (US), Hi-Media Laboratories (India), Liofilchem S.r.l. (Italy), Alifax S.r.l. (Italy), Creative Diagnostics (US), Synbiosis (UK), Bioanalyse (Turkey), ZHUHAI DL BIOTECH Co., Ltd. (China), ELITechGroup (France), Mast Group Ltd. (UK), CONDALAB (Spain), Genefluidics, Inc. (US), Biotron Ltd (Australia), InvivoGen (US), MP Biomedicals (US), QuantaMatrix Inc. (South Korea), and PML Microbiologicals Inc. (US), among others are some of the major players operating in the global AST market.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=206359984&utm_source=openpr&utm_medium=paidpr

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antimicrobial Susceptibility Testing Market worth $4.2 billion by 2025 - Leading Key Players are bioMérieux SA (France), Becton, Dickinson and Company (US), Thermo Fisher Scientific (US) here

News-ID: 2226654 • Views:

More Releases from MarketsandMarkets™

Feed Premix Market, Global Industry Size Forecast
The global feed premix market size is estimated to be valued at USD 24.3 billion in 2021 and is projected to reach a value of USD 32.9 billion by 2026, growing at a CAGR of 6.2% during the forecast period. The growth of this market is attributed to increasing awareness about feed quality, and the implementation of innovative animal husbandry practices to improve meat quality are the important drivers for
Water-soluble Fertilizers Market is Expected to Grow $23.9 billion in 2028
According to a research report "Water-soluble Fertilizers Market by Type (Nitrogenous, Phosphatic, and Potassic), Mode of Application (Foliar and Fertigation), Form (Dry and Liquid), Crop Type (Field Crop, Horticulture Crops, Turf & ornaments) and Region - Global Forecast to 2028" published by MarketsandMarkets, the water-soluble fertilizers market is estimated at USD 18.3 billion in 2023 and is projected to reach USD 23.9 billion in 2028, at a CAGR of 5.5%.
Population Health Management (PHM) Market worth $53.3 billion by 2027 - Leading Key Players are Cerner Corporation (US), Epic Systems Corporation (US), Koninklijke Philips (Netherlands)
Population Health Management (PHM) Market worth $53.3 billion by 2027 - Leading …
Population Health Management (PHM) Market is projected to grow from USD 27.8 billion in 2022 to USD 53.3 billion by 2027, at a CAGR of 13.9% from 2022 to 2027, according to a new report by MarketsandMarkets™. The Growth in this market is driven by the opportunities offered by the emerging markets in healthcare. However, lack of data management, and interoperability issues are expected to challenge the growth of this
Veterinary Pain Management Market worth $2.5 billion - Leading Key Players are Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (US), Elanco Animal Health Incorporated (US), Merck & Co., Inc. (US)
Veterinary Pain Management Market worth $2.5 billion - Leading Key Players are B …
Veterinary Pain Management Market is projected to grow from USD 1.8 billion in 2022 to USD 2.5 billion by 2027, at a CAGR of 6.7% from 2022 to 2027, according to a new report by MarketsandMarkets™. The Pain is the physiological term to describe the chemical processes that are at work in the body that receive a stimulus, modify it, and transfer it to the brain for interpretation and reaction.

All 5 Releases


More Releases for Susceptibility

Antimicrobial Susceptibility Testing Market Research Report Study by 2031
Antimicrobial Susceptibility Testing Market: Overview The popularity of antimicrobial susceptibility testing (AST) technologies has stemmed from the prevalence of infectious diseases that are of bacterial origin. This has propelled a steady evolution for the antimicrobial susceptibility testing (AST) market. AST is comprised of lab procedure used by medical technologists in general or clinical laboratory scientists specifically to identify the best or most suitable antimicrobial regimen for treating individual patients. AST has been found
Antimicrobial Susceptibility Testing Market Challenging Health Concerns 2030
Antimicrobial Susceptibility Testing Market: Overview The popularity of antimicrobial susceptibility testing (AST) technologies has stemmed from the prevalence of infectious diseases that are of bacterial origin. This has propelled a steady evolution for the antimicrobial susceptibility testing (AST) market. AST is comprised of lab procedure used by medical technologists in general or clinical laboratory scientists specifically to identify the best or most suitable antimicrobial regimen for treating individual patients. AST
Susceptibility Gene Detection Market: Competitive Dynamics & Global Outlook 2020 …
Global Info Research offers a latest published report on Susceptibility Gene Detection Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Susceptibility Gene Detection Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
Antimicrobial Susceptibility Test Market Highlights On Future Development 2027
Transparency Market Research (TMR) has published a new report titled, ‘Antimicrobial Susceptibility Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global Antimicrobial Susceptibility Test market was valued at US$ 2,770.9 Mn in 2018 and is projected to expand at a CAGR of 4.9% from 2019 to 2027. Read Report Overview - https://www.transparencymarketresearch.com/antimicrobial-susceptibility-testing-market.html Overview Antimicrobial susceptibility test can be defined as a procedure employed
Antimicrobial Susceptibility Tester Market to Set Phenomenal Growth by 2028
Antimicrobial Susceptibility Tester Market: Overview Evolution in bacteria, viruses, fungus, and other microorganisms is a challenge for today’s medical technology, since evolution in these living organisms is reducing the effect of traditional medicines. Fetal diseases and blood-borne diseases are spreading very fast due to environmental changes such as global warming and others. For controlling such diseases, research is being performed to find out effective medicines, antibiotics, and other immune boosters. For
Antimicrobial Susceptibility Test Market worth US$ 3,814.0 Mn by 2025
Antimicrobial Susceptibility Test Market – Snapshot Antimicrobial susceptibility tests are used to determine the specific antibiotics to be used in order to treat a particular infection caused by bacteria or fungus. Antimicrobial susceptibility testing is essential to identify the patients’ antibiotic treatment and fight against antibiotic resistance. View Report- https://www.transparencymarketresearch.com/antimicrobial-susceptibility-testing-market.html The global antimicrobial susceptibility test market was valued at US$ 2,578.4 Mn in 2016 and is anticipated to expand at a CAGR of 4.6%